The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 14, 2020

Filed:

Feb. 19, 2016
Applicant:

Immune Biosolutions Inc., Sherbrooke, CA;

Inventors:

Simon Gaudreau, Sherbrooke, CA;

Martin Cloutier, Sherbrooke, CA;

Louis-Charles Fortier, Sherbrooke, CA;

Frederic Leduc, Sherbrooke, CA;

Maxime Tremblay, Sherbrooke, CA;

Steeve Veronneau, Cookshire-Eaton, CA;

Djorjde Gbric, Sherbrooke, CA;

Jean-Francois Larrivee, Sherbrooke, CA;

Assignee:

IMMUNE BIOSOLUTIONS INC, Sherbrooke, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/33 (2006.01); C07K 16/12 (2006.01); C07K 16/46 (2006.01); C12N 15/85 (2006.01); A61K 39/08 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/33 (2013.01); C07K 16/1282 (2013.01); C07K 16/46 (2013.01); C12N 15/85 (2013.01); A61K 39/08 (2013.01); A61K 2039/505 (2013.01); C07K 2317/34 (2013.01); C07K 2317/76 (2013.01);
Abstract

It is described a(-) toxins A and/or B as a target for therapy, including passive immunotherapy, and particularly prevention of-intoxication in human or other animals. It is also described a polypeptide comprising a portion of-toxins A and/or B sequence being an epitope for anti-toxins A and/or B antibody. It is also disclosed a method for generating a neutralizing antibody directed against-toxins A and/or B. It is also provided a novel formulation that combines key toxins A and/or B epitope antibodies, located in three key domains of toxins A and/or B, for neutralizing toxins A and/or B, at any stage of toxins A and/or B intoxication related to-infection. The novel formulation of toxins A and/or B epitope antibodies are useful in immunotherapy, for therapeutic and/or prophylactic mediation of-intoxication.


Find Patent Forward Citations

Loading…